← Back to all trials
Recruiting
NCT07548632
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Conditions: Dry Eye Disease (DED)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2, PHASE3
Enrollment: 160
Sponsor: Oculis
Location: East West Eye Institute Aliso Viejo California
Summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Eligibility Criteria
Key Inclusion Criteria:
* Physician diagnosis of Dry Eye Disease in the past 6 months
* Use of over-the-counter tears
* Must agree to genotype testing
Key Exclusion Criteria:
\- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety.
Source: ClinicalTrials.gov (NCT07548632). StuddyBuddy aggregates publicly available trial information.
